BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38374060)

  • 21. The value of dementia care towards the end of life-A contingent valuation study.
    Bhattarai N; Mason H; Kernohan A; Poole M; Bamford C; Robinson L; Vale L
    Int J Geriatr Psychiatry; 2020 May; 35(5):489-497. PubMed ID: 31912572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
    Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
    Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey.
    Nguyen QL; Nguyen LH; Tran BX; Phan HT; Le HT; Nguyen HD; Tran TD; Do CD; Nguyen CM; Thuc VT; Latkin C; Zhang MW; Ho RC
    PLoS One; 2017; 12(2):e0172050. PubMed ID: 28199405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Willingness to Pay for Mandibular Overdentures: A Societal Perspective.
    Srivastava A; Esfandiari S; Madathil SA; Birch S; Feine JS
    JDR Clin Trans Res; 2020 Jan; 5(1):30-39. PubMed ID: 31067410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios.
    Isah A; Adibe MO; Abba A; Dim OF; Ekwuofu AA; Ma'aji HU; Ukwe CV; Udeogaranya PO; Okonta MJ
    J Clin Pharm Ther; 2021 Dec; 46(6):1695-1705. PubMed ID: 34448210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Willingness to pay for public health services in rural Central Java, Indonesia: methodological considerations when using the contingent valuation method.
    Shono A; Kondo M; Ohmae H; Okubo I
    Soc Sci Med; 2014 Jun; 110():31-40. PubMed ID: 24713191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness to pay for community-based health insurance in Nigeria: do economic status and place of residence matter?
    Onwujekwe O; Okereke E; Onoka C; Uzochukwu B; Kirigia J; Petu A
    Health Policy Plan; 2010 Mar; 25(2):155-61. PubMed ID: 20156920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness to pay for COVID-19 vaccines: Applying the health belief model.
    Arabyat RM; Nusair MB; Al-Azzam SI; Amawi HA; El-Hajji FD
    Res Social Adm Pharm; 2023 Jan; 19(1):95-101. PubMed ID: 36153237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Willingness to pay for diagnostic technologies: a review of the contingent valuation literature.
    Lin PJ; Cangelosi MJ; Lee DW; Neumann PJ
    Value Health; 2013; 16(5):797-805. PubMed ID: 23947973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consumers' Willingness to Pay for Pharmacist Counselling Services and the Factors Affecting It in Community Pharmacies.
    Soodi O; Hesari E; Hojjatifard R; Seyedifar M
    Iran J Pharm Res; 2023; 22(1):e132736. PubMed ID: 38116550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of Electroconvulsive Therapy in the General Public: A Willingness to Pay Study in Germany.
    Ulbrich L; Kröger C
    J ECT; 2021 Mar; 37(1):51-57. PubMed ID: 33009216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Willingness to participate and Pay for a proposed national health insurance in St. Vincent and the grenadines: a cross-sectional contingent valuation approach.
    Adams R; Chou YJ; Pu C
    BMC Health Serv Res; 2015 Apr; 15():148. PubMed ID: 25890181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Willingness to pay for lung cancer treatment.
    Lang HC
    Value Health; 2010; 13(6):743-9. PubMed ID: 20561327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery.
    Haefeli M; Elfering A; McIntosh E; Gray A; Sukthankar A; Boos N
    Value Health; 2008; 11(4):575-88. PubMed ID: 18179657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Financing COVID-19 vaccination in sub-Saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana.
    Alhassan RK; Nketiah-Amponsah E; Immurana M; Abuosi AA
    BMC Public Health; 2022 Jun; 22(1):1273. PubMed ID: 35773637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Willingness to pay for the maintenance of equity in a local ivermectin distribution scheme in Toro, Northern Nigeria.
    Onwujekwe OE; Shu EN; Okonkwo PO
    Public Health; 1999 Jul; 113(4):193-4. PubMed ID: 10483083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valuing Mobile Health: An Open-Ended Contingent Valuation Survey of a National Digital Health Program.
    Somers C; Grieve E; Lennon M; Bouamrane MM; Mair FS; McIntosh E
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e3. PubMed ID: 30664488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Willingness to pay and the sensitivity of willingness to pay for interdisciplinary musculoskeletal clinics: a contingent valuation study in Quebec, Canada.
    Poder TG; He J
    Int J Health Econ Manag; 2016 Dec; 16(4):337-361. PubMed ID: 27878690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing preferences for prevention versus treatment using willingness to pay.
    Corso PS; Hammitt JK; Graham JD; Dicker RC; Goldie SJ
    Med Decis Making; 2002; 22(5 Suppl):S92-101. PubMed ID: 12369235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.